Free Trial
NASDAQ:KMTS

Kestra Medical Technologies (KMTS) Stock Price, News & Analysis

Kestra Medical Technologies logo
$14.67 +0.02 (+0.14%)
As of 01:33 PM Eastern

About Kestra Medical Technologies Stock (NASDAQ:KMTS)

Key Stats

Today's Range
$14.40
$14.76
50-Day Range
$14.46
$21.17
52-Week Range
$13.25
$26.15
Volume
54,748 shs
Average Volume
279,874 shs
Market Capitalization
$753.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.33
Consensus Rating
Moderate Buy

Company Overview

Kestra Medical Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

KMTS MarketRank™: 

Kestra Medical Technologies scored higher than 27% of companies evaluated by MarketBeat, and ranked 1636th out of 1,853 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Kestra Medical Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Kestra Medical Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about Kestra Medical Technologies' stock forecast and price target.
  • Price to Book Value per Share Ratio

    Kestra Medical Technologies has a P/B Ratio of 3.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for KMTS.
  • Dividend Yield

    Kestra Medical Technologies does not currently pay a dividend.

  • Dividend Growth

    Kestra Medical Technologies does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for KMTS.
  • News Sentiment

    Kestra Medical Technologies has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Kestra Medical Technologies this week, compared to 2 articles on an average week.
Receive KMTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kestra Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

KMTS Stock News Headlines

KMTS Kestra Medical Technologies, Ltd. - Seeking Alpha
My shocking meeting in Washington, D.C.
After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look inside Trump’s genius master plan to create a “new” gold standard, smash the U.S. debt, and kick off a Golden Century.
See More Headlines

KMTS Stock Analysis - Frequently Asked Questions

Kestra Medical Technologies' stock was trading at $20.99 at the start of the year. Since then, KMTS shares have decreased by 30.3% and is now trading at $14.64.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) posted its quarterly earnings results on Monday, April, 14th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.64) by $0.61.
Read the conference call transcript
.

Kestra Medical Technologies (KMTS) raised $202 million in an initial public offering on Thursday, March 6th 2025. The company issued 11,882,352 shares at a price of $17.00 per share.

Kestra Medical Technologies's lock-up period expires on Tuesday, September 2nd. Kestra Medical Technologies had issued 11,882,352 shares in its IPO on March 6th. The total size of the offering was $201,999,984 based on an initial share price of $17.00. After the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Kestra Medical Technologies' top institutional investors include Franklin Resources Inc. (0.86%), Geode Capital Management LLC (0.63%), Jennison Associates LLC (0.26%) and TD Asset Management Inc (0.15%).

Shares of KMTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/14/2025
Today
8/12/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:KMTS
Previous Symbol
NASDAQ:KMTS
CIK
1877184
Web
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$23.00
Potential Upside/Downside
+86.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
6.72
Quick Ratio
6.72

Sales & Book Value

Annual Sales
$59.81 million
Price / Sales
12.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.00 per share
Price / Book
3.67

Miscellaneous

Outstanding Shares
51,350,000
Free Float
49,500,000
Market Cap
$753.30 million
Optionable
N/A
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:KMTS) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners